By Megan Rauscher NEW YORK (Reuters Health) - A team of U.S. scientists has identified a new family of compounds that block the ability of estrogen to stimulate the growth of breast cancer cells. "The lead inhibitor is quite effective in breast cancer cells that are resistant to tamoxifen," Dr

LONDON, June 12 (Reuters) - GlaxoSmithKline Plc has received formal European marketing authorisation for its new breast cancer pill Tyverb, the world's second biggest drugmaker said on Thursday. The green light from the European Commission, granting the medicine a conditional marketing authorisat

WASHINGTON (Reuters Life!) - The osteoporosis drug Evista can help prevent breast cancer -- but only the type fueled by the hormone estrogen, researchers reported on Tuesday. So-called estrogen-receptor-positive breast cancer is the most common type and women who took Eli Lilly and Co's Evista we

Utrecht (Sp!ts), 3 June 2008 - Half of the women with breast cancer has sexual problems during and after treatment. This is based on a study performed by the Rutgers Nisso Group, commissioned by the BortkankerVereniging Nederland (BVN). Due to the operations, and extended treatment, women experience

By Martha Kerr NEW YORK (Reuters Health) - An novel investigational chemotherapy regimen targeting both a mutated protein called p53 and tumor blood vessels "has complementary and potent antitumor activity and could define a new strategy for suppression of advanced breast cancers," Dr. Yayun Lian

By Deena Beasley CHICAGO, May 31 (Reuters) - The addition of Genentech Inc's (DNA.N: Quote, Profile, Research, Stock Buzz) cancer drug Avastin to chemotherapy slows the progress of breast cancer at two different doses, according to results of a large international trial released on Saturday. T

By Susan Kelly CHICAGO, May 31 (Reuters) - Swiss drugmaker Roche Holding AG's (ROG.VX: Quote, Profile, Research, Stock Buzz) oral chemotherapy drug Xeloda, or capecitabine, proved inferior to standard chemotherapy in treating older women with early stage breast cancer, a study released on Saturda

By Joene Hendry NEW YORK (Reuters Health) - Results from a decades-long study may enable women to drink coffee or tea without worry that doing so will increase their risk for breast cancer, study findings suggest. "In this large cohort of women, with 22 years of follow-up, we observed no assoc

By Kim Dixon WASHINGTON (Reuters) - A congressional panel on Wednesday said it has bipartisan support for a bill requiring health insurers to pay for a minimum 48-hour hospital stay after breast cancer treatment, to combat what critics call "drive-through" surgeries. About 20 U.S. states have su

The French medical journal La Généraliste, reports that breast cancer might be detectable through hair and saliva in the future. Certain molecules that are common in breast cancer tumors, can also be present in the patients skin. But, the tumor does not only cause changes to the skin, it can also c